Looking for a chapter closer to you? Click here.

Artificial Pancreas

More GOOD News from the FDA

by Kimberly Ford Chisholm 02.03.2012 Lessons Earned

Stanford University and the FDA announced a collaboration on January 12, 2012 that will lead to more efficient and effective methods of establishing the safety and efficacy of medications and devices.

Read the full article →

JDRF Encouraged By Draft FDA Artificial Pancreas Guidance

by JDRF Bay Area 12.09.2011 Advocacy

FDA’s Draft Guidance is a first step to providing access to life-saving technology for millions with type 1 diabetes.

Read the full article →

JDRF’s CEO on Recent Progress on the Artificial Pancreas

by JDRF Bay Area 12.06.2011 Advocacy

JDRF’s President & CEO, Jeffrey Brewer, writes about the FDA’s Draft Guidance for an Artificial Pancreas, and the story of how we got to this point.

Read the full article →

“A Very Good Day”: The FDA Delivers on its Promise to Aid in the Fight Against Type 1 Diabetes

by Kimberly Ford Chisholm 12.02.2011 Lessons Earned

FInd out why December 1 was a “very good day” for people with type 1 diabetes.

Read the full article →

U.S. Senators, Clinicians and People with Type 1 Diabetes Urge FDA to Issue Clear and Reasonable Guidance on Artificial Pancreas

by JDRF Bay Area 11.02.2011 Advocacy

If the FDA fails to issue guidance that adopts recommendations from leading clinical experts, patient access will inevitably be delayed and even prevented entirely. This is an opportunity for the FDA to demonstrate its commitment to meeting its goal of closing the agency’s regulatory science gap.

Read the full article →

Major Day for Artificial Pancreas Advancement

by JDRF Bay Area 10.28.2011 Advocacy

JDRF-funded researchers report success with first automated real-world study in type 1 diabetes patients; JDRF applauds recent FDA approval to conduct low-glucose suspend device clinical trial at home.

Read the full article →